<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03190681</url>
  </required_header>
  <id_info>
    <org_study_id>C13-08</org_study_id>
    <nct_id>NCT03190681</nct_id>
  </id_info>
  <brief_title>Motivation and Methylphenidate</brief_title>
  <acronym>MBB_MPH</acronym>
  <official_title>Etude Comparative Monocentrique, randomisée, en Cross-over, en Double Aveugle, Contre Placebo, de l'Action du méthylphénidate Sur Les paramètres Cognitifs de la Motivation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the impact of methylphenidate, a mixed dopaminergic
      and noradrenergic agent, onto the different components of motivation: decision-making, effort
      allocation and instrumental learning.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2017</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>coefficient of sensitivity to reward</measure>
    <time_frame>two hours after administration</time_frame>
    <description>Parameter characterizing the influence of reward expectation/experience onto behavior for each individual.
This parameter is estimated through the fit of computational models to behaviors recorded in a battery of motivational tasks (choice task, effort task, Learning task).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>coefficient of sensitivity to effort</measure>
    <time_frame>two hours after administration</time_frame>
    <description>Parameter characterizing the influence of effort expectation/experience onto behavior for each individual.
This parameter is estimated through the fit of computational models to behaviors recorded in a battery of motivational tasks (choice task, effort task, Learning task).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>coefficient of sensitivity to punishment</measure>
    <time_frame>two hours after administration</time_frame>
    <description>Parameter characterizing the influence of punishment expectation/experience onto behavior for each individual.
This parameter is estimated through the fit of computational models to behaviors recorded in a battery of motivational tasks (choice task, effort task, Learning task).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>coefficient of sensitivity to delay</measure>
    <time_frame>two hours after administration</time_frame>
    <description>Parameter characterizing the influence of delay expectation onto behavior for each individual.
This parameter is estimated through the fit of computational models to behaviors recorded in a battery of motivational tasks (choice task, effort task, Learning task).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Motivation</condition>
  <condition>Apathy</condition>
  <condition>Impulsive Behavior</condition>
  <arm_group>
    <arm_group_label>methylphenidate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>inactive pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ritalin 10Mg Tablet</intervention_name>
    <description>ingestion of an oral single-dose</description>
    <arm_group_label>methylphenidate</arm_group_label>
    <arm_group_label>inactive pill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  weight&gt;= 50kg and &lt;=90kg

          -  free and informed consent

          -  social security affiliation

          -  no chronic illness

          -  no previous participation to a protocol wth similar tasks

          -  no special legal status (guardianship,trusteeship)

          -  no personnal or familial neurologic or psychiatric background

          -  no contraceptive device for a reproductive woman

        Exclusion Criteria:

          -  inability to squeeze a handgrip

          -  smoking

          -  psychoactive substance consumption less than 3 weeks ago

          -  pregnant or breastfeeding woman

          -  hypersensitivity to methylphenidate

          -  hyperthyroidism

          -  cardiovascular or cerebrovascular disease

          -  respiratory, hepatic or renal failure

          -  glaucoma

          -  pheochromocytoma

          -  gluten intolerance or hypersensitivity

          -  galactosemia, glucose malabsorption syndrome, lactase deficit

          -  countraindicated meds (IMAO, IMAO-A, orhtosympathomimetics, alcaloids, linezolin,
             enzymatic inducers, psycho-active drugs)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre d'investigation clinique, Institut du Cerveau et de la Moelle</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Christophe CORVOL, MD</last_name>
      <phone>+33142165773</phone>
      <email>jean-christophe.corvol@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2017</study_first_submitted>
  <study_first_submitted_qc>June 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2017</study_first_posted>
  <last_update_submitted>June 14, 2017</last_update_submitted>
  <last_update_submitted_qc>June 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut National de la Santé Et de la Recherche Médicale, France</investigator_affiliation>
    <investigator_full_name>Jean-Christophe CORVOL</investigator_full_name>
    <investigator_title>clinical investigation center director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Impulsive Behavior</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylphenidate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

